NCT03042442View on ClinicalTrials.gov

Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers Substudy

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

September 30, 2018

Conditions
Pancreatic Cancer, AdultCachexiaPainDiabetes Mellitus
Interventions
DIAGNOSTIC_TEST

Point-of care biomarkers

Point-of care biomarkers(Activin,Midkine) assessed by WB and IHC

OTHER

Clinical, venous blood samples, pancreatic tissue

Clinical evaluation, venous blood samples and pancreatic tissue needed for determining point-of-care biomarkers.

OTHER

Follow-up

Participants will be assessed (by telephone) over a period of 2 years

Trial Locations (1)

400192

Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca

All Listed Sponsors
lead

Iuliu Hatieganu University of Medicine and Pharmacy

OTHER

NCT03042442 - Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers Substudy | Biotech Hunter | Biotech Hunter